{"transactions":[{"id":689282,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Restricted Stock Units","published_at":"2026-08-12T17:01:36.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":true,"shares":11519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon & Co. (\"Organon\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments with the third and final vesting occurring on August 11, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments with the third and final vesting occurring on August 11, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11519},"source":{"system":"sec-edgar","filing":"0001628280-26-056061","document":"wk-form4_1786554094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828026056061/wk-form4_1786554094.xml","form_type":"4"}},{"id":689281,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2026-08-12T17:01:36.000Z","date":"2026-08-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":4134,"price":13.62,"value":56305.08,"ownership":{"direct":true},"balance_after":37432.477,"source":{"system":"sec-edgar","filing":"0001628280-26-056061","document":"wk-form4_1786554094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828026056061/wk-form4_1786554094.xml","form_type":"4"}},{"id":689280,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2026-08-12T17:01:36.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":true,"shares":11519,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41566.477,"source":{"system":"sec-edgar","filing":"0001628280-26-056061","document":"wk-form4_1786554094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828026056061/wk-form4_1786554094.xml","form_type":"4"}},{"id":819655,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Restricted Stock Units","published_at":"2026-04-02T20:18:37.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":false,"shares":13431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 31, 2025, the Reporting Person was granted 40,295 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 31, 2025, the Reporting Person was granted 40,295 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028."}],"balance_after":26864,"derivative":{"underlying":"Common Stock","underlying_shares":13431},"source":{"system":"sec-edgar","filing":"0001628280-26-023188","document":"wk-form4_1775161114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828026023188/wk-form4_1775161114.xml","form_type":"4"}},{"id":819654,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Restricted Stock Units","published_at":"2026-04-02T20:18:37.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":200333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On March 31, 2026, the Reporting Person was granted 200,333 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 31, 2026, the Reporting Person was granted 200,333 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 31, 2026, the Reporting Person was granted 200,333 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."}],"balance_after":200333,"derivative":{"underlying":"Common Stock","underlying_shares":200333},"source":{"system":"sec-edgar","filing":"0001628280-26-023188","document":"wk-form4_1775161114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828026023188/wk-form4_1775161114.xml","form_type":"4"}},{"id":819653,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2026-04-02T20:18:37.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4820,"price":5.7,"value":27474.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is the closing market price of Organon & Co. (\"Organon\") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":30047.477,"source":{"system":"sec-edgar","filing":"0001628280-26-023188","document":"wk-form4_1775161114.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828026023188/wk-form4_1775161114.xml","form_type":"4"}},{"id":819652,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2026-04-02T20:18:37.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":13431,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34867.477,"source":{"system":"sec-edgar","filing":"0001628280-26-023188","document":"wk-form4_1775161114.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828026023188/wk-form4_1775161114.xml","form_type":"4"}},{"id":824174,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Restricted Stock Units","published_at":"2026-03-31T20:09:22.000Z","date":"2026-03-29","kind":"exercise","planned":false,"acquired":false,"shares":8865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."}],"balance_after":8865,"derivative":{"underlying":"Common Stock","underlying_shares":8865},"source":{"system":"sec-edgar","filing":"0001628280-26-022387","document":"wk-form4_1774987760.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828026022387/wk-form4_1774987760.xml","form_type":"4"}},{"id":824173,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2026-03-31T20:09:22.000Z","date":"2026-03-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":3181,"price":5.84,"value":18577.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the closing market price of Organon common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the addition of 708.122 shares of Organon common stock acquired from dividend equivalents net of withholding tax not previously required to be reported."}],"balance_after":21436.477,"source":{"system":"sec-edgar","filing":"0001628280-26-022387","document":"wk-form4_1774987760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828026022387/wk-form4_1774987760.xml","form_type":"4"}},{"id":824172,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2026-03-31T20:09:22.000Z","date":"2026-03-29","kind":"exercise","planned":false,"acquired":true,"shares":8865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The total number of shares reported as beneficially owned has been reduced to reflect 13,872 shares of Organon & Co. (\"Organon\") common stock transferred pursuant to an exemption under Exchange Act Rule 16a-12."}],"balance_after":23909.355,"source":{"system":"sec-edgar","filing":"0001628280-26-022387","document":"wk-form4_1774987760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828026022387/wk-form4_1774987760.xml","form_type":"4"}},{"id":1003758,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Restricted Stock Units","published_at":"2025-11-10T21:14:08.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":false,"shares":6446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon & Co. (\"Organon\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Organon common stock in three installments: 6,446 shares on November 7 2024; 6,446 shares on November 7, 2025; and 6,447 shares on November 7, 2026."}],"balance_after":6447,"derivative":{"exercise_date":"2024-11-07","expiration_date":"2026-11-07","underlying":"Common Stock","underlying_shares":6446},"source":{"system":"sec-edgar","filing":"0001628280-25-051052","document":"wk-form4_1762809245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828025051052/wk-form4_1762809245.xml","form_type":"4"}},{"id":1003757,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2025-11-10T21:14:08.000Z","date":"2025-11-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":2307,"price":6.71,"value":15479.97,"ownership":{"direct":true},"balance_after":28916.355,"source":{"system":"sec-edgar","filing":"0001628280-25-051052","document":"wk-form4_1762809245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828025051052/wk-form4_1762809245.xml","form_type":"4"}},{"id":1003756,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2025-11-10T21:14:08.000Z","date":"2025-11-07","kind":"exercise","planned":false,"acquired":true,"shares":6446,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31223.355,"source":{"system":"sec-edgar","filing":"0001628280-25-051052","document":"wk-form4_1762809245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000162828025051052/wk-form4_1762809245.xml","form_type":"4"}},{"id":1068943,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Restricted Stock Units","published_at":"2025-08-12T20:05:37.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":11519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Organon & Co. common stock in three equal installments with 11,519 shares having vested on August 11, 2025 and the third and final vesting to occur on August 11, 2026."}],"balance_after":11519,"derivative":{"exercise_date":"2025-08-11","expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":11519},"source":{"system":"sec-edgar","filing":"0001821825-25-000068","document":"wk-form4_1755029130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182525000068/wk-form4_1755029130.xml","form_type":"4"}},{"id":1068942,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2025-08-12T20:05:37.000Z","date":"2025-08-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":4122,"price":9.22,"value":38004.84,"ownership":{"direct":true},"balance_after":24777.355,"source":{"system":"sec-edgar","filing":"0001821825-25-000068","document":"wk-form4_1755029130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182525000068/wk-form4_1755029130.xml","form_type":"4"}},{"id":1068941,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2025-08-12T20:05:37.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":true,"shares":11519,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28899.355,"source":{"system":"sec-edgar","filing":"0001821825-25-000068","document":"wk-form4_1755029130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182525000068/wk-form4_1755029130.xml","form_type":"4"}},{"id":1183582,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:40:55.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":8865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day."}],"balance_after":17730,"derivative":{"underlying":"Common Stock","underlying_shares":8865},"source":{"system":"sec-edgar","filing":"0001821825-25-000012","document":"wk-form4_1743630049.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182525000012/wk-form4_1743630049.xml","form_type":"4"}},{"id":1183581,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:40:55.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":40295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028."}],"balance_after":40295,"derivative":{"underlying":"Common Stock","underlying_shares":40295},"source":{"system":"sec-edgar","filing":"0001821825-25-000012","document":"wk-form4_1743630049.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182525000012/wk-form4_1743630049.xml","form_type":"4"}},{"id":1183580,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T21:40:55.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":198019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028."}],"balance_after":198019,"derivative":{"exercise_price":14.89,"underlying":"Common Stock","underlying_shares":198019},"source":{"system":"sec-edgar","filing":"0001821825-25-000012","document":"wk-form4_1743630049.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182525000012/wk-form4_1743630049.xml","form_type":"4"}},{"id":1183579,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2025-04-02T21:40:55.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":3172,"price":14.51,"value":46025.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":17380.355,"source":{"system":"sec-edgar","filing":"0001821825-25-000012","document":"wk-form4_1743630049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182525000012/wk-form4_1743630049.xml","form_type":"4"}},{"id":1183578,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2025-04-02T21:40:55.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":8865,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20552.355,"source":{"system":"sec-edgar","filing":"0001821825-25-000012","document":"wk-form4_1743630049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182525000012/wk-form4_1743630049.xml","form_type":"4"}},{"id":1371442,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Restricted Stock Units","published_at":"2024-11-08T21:17:43.000Z","date":"2024-11-07","kind":"exercise","planned":false,"acquired":false,"shares":6446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Organon & Co. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On November 7, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two installments on November 7, 2025 and November 7, 2026."}],"balance_after":12893,"derivative":{"exercise_date":"2024-11-07","expiration_date":"2026-11-07","underlying":"Common Stock","underlying_shares":6446},"source":{"system":"sec-edgar","filing":"0001821825-24-000110","document":"wk-form4_1731100655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182524000110/wk-form4_1731100655.xml","form_type":"4"}},{"id":1371441,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2024-11-08T21:17:43.000Z","date":"2024-11-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":2300,"price":15.8,"value":36340.0,"ownership":{"direct":true},"balance_after":11687.355,"source":{"system":"sec-edgar","filing":"0001821825-24-000110","document":"wk-form4_1731100655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182524000110/wk-form4_1731100655.xml","form_type":"4"}},{"id":1371440,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2024-11-08T21:17:43.000Z","date":"2024-11-07","kind":"exercise","planned":false,"acquired":true,"shares":6446,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13987.355,"source":{"system":"sec-edgar","filing":"0001821825-24-000110","document":"wk-form4_1731100655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182524000110/wk-form4_1731100655.xml","form_type":"4"}},{"id":1436021,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Restricted Stock Units","published_at":"2024-08-12T21:18:14.000Z","date":"2024-08-11","kind":"exercise","planned":false,"acquired":false,"shares":11519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Organon & Co. common stock in three equal installments of 11,519 shares on each of August 11, 2024; August 11, 2025; and August 11, 2026."}],"balance_after":23038,"derivative":{"exercise_date":"2024-08-11","expiration_date":"2026-08-11","underlying":"Common Stock","underlying_shares":11519},"source":{"system":"sec-edgar","filing":"0001821825-24-000085","document":"wk-form4_1723497488.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182524000085/wk-form4_1723497488.xml","form_type":"4"}},{"id":1436020,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2024-08-12T21:18:14.000Z","date":"2024-08-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3991,"price":20.15,"value":80418.65,"ownership":{"direct":true},"balance_after":7541.355,"source":{"system":"sec-edgar","filing":"0001821825-24-000085","document":"wk-form4_1723497488.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182524000085/wk-form4_1723497488.xml","form_type":"4"}},{"id":1436019,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Common Stock","published_at":"2024-08-12T21:18:14.000Z","date":"2024-08-11","kind":"exercise","planned":false,"acquired":true,"shares":11519,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11532.355,"source":{"system":"sec-edgar","filing":"0001821825-24-000085","document":"wk-form4_1723497488.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182524000085/wk-form4_1723497488.xml","form_type":"4"}},{"id":1541262,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-16T10:23:35.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":108932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."}],"balance_after":108932,"derivative":{"exercise_price":18.8,"exercise_date":"2025-03-29","expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":108932},"source":{"system":"sec-edgar","filing":"0001821825-24-000053","document":"wk-form4_1713263007.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182524000053/wk-form4_1713263007.xml","form_type":"4"}},{"id":1541261,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D & CMO"}}],"security":"Restricted Stock Units","published_at":"2024-04-16T10:23:35.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":26595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."}],"balance_after":26595,"derivative":{"exercise_price":0,"exercise_date":"2025-03-29","expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":26595},"source":{"system":"sec-edgar","filing":"0001821825-24-000053","document":"wk-form4_1713263007.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000182182524000053/wk-form4_1713263007.xml","form_type":"4"}},{"id":1958852,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Performance Stock Unit","published_at":"2023-03-10T14:24:59.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":103703,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each performance-based restricted stock unit (\"PSU\") outstanding immediately prior to the Effective Time that had not been settled in Issuer common shares was canceled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash, without interest, equal to the product of (a) the Per Share Consideration, multiplied by (b) the total number of Issuer common shares subject to such PSUs (deeming performance goals as being satisfied) immediately prior to the Effective Time."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Each performance-based restricted stock unit (\"PSU\") outstanding immediately prior to the Effective Time that had not been settled in Issuer common shares was canceled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash, without interest, equal to the product of (a) the Per Share Consideration, multiplied by (b) the total number of Issuer common shares subject to such PSUs (deeming performance goals as being satisfied) immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Each performance-based restricted stock unit (\"PSU\") outstanding immediately prior to the Effective Time that had not been settled in Issuer common shares was canceled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash, without interest, equal to the product of (a) the Per Share Consideration, multiplied by (b) the total number of Issuer common shares subject to such PSUs (deeming performance goals as being satisfied) immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Each performance-based restricted stock unit (\"PSU\") outstanding immediately prior to the Effective Time that had not been settled in Issuer common shares was canceled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash, without interest, equal to the product of (a) the Per Share Consideration, multiplied by (b) the total number of Issuer common shares subject to such PSUs (deeming performance goals as being satisfied) immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":103703},"source":{"system":"sec-edgar","filing":"0001209191-23-017715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919123017715/doc4.xml","form_type":"4"}},{"id":1958851,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-10T14:24:59.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":79472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each then-outstanding and unexercised Issuer stock option (whether vested or unvested) was canceled and converted into the right to receive an amount (subject to any withholding tax) in cash, without interest, equal to the product of (a) the excess, if any, of (i) the Per Share Consideration over (ii) the applicable exercise price for such option, multiplied by (b) the total number of Issuer common shares subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One-fourth of the options vested on April 15, 2022, and one-sixteenth of the options vest each quarter thereafter."}],"balance_after":0,"derivative":{"exercise_price":17.88,"expiration_date":"2031-04-14","underlying":"Common Shares","underlying_shares":79472},"source":{"system":"sec-edgar","filing":"0001209191-23-017715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919123017715/doc4.xml","form_type":"4"}},{"id":1958850,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-10T14:24:59.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":134464,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each then-outstanding and unexercised Issuer stock option (whether vested or unvested) was canceled and converted into the right to receive an amount (subject to any withholding tax) in cash, without interest, equal to the product of (a) the excess, if any, of (i) the Per Share Consideration over (ii) the applicable exercise price for such option, multiplied by (b) the total number of Issuer common shares subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-fourth of the options vested on April 3, 2021, and one-sixteenth of the options vest each quarter thereafter."}],"balance_after":0,"derivative":{"exercise_price":8.08,"expiration_date":"2030-04-02","underlying":"Common Shares","underlying_shares":134464},"source":{"system":"sec-edgar","filing":"0001209191-23-017715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919123017715/doc4.xml","form_type":"4"}},{"id":1958849,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-10T14:24:59.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":65863,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each then-outstanding and unexercised Issuer stock option (whether vested or unvested) was canceled and converted into the right to receive an amount (subject to any withholding tax) in cash, without interest, equal to the product of (a) the excess, if any, of (i) the Per Share Consideration over (ii) the applicable exercise price for such option, multiplied by (b) the total number of Issuer common shares subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-fourth of the options vested on April 5, 2020, and one-sixteenth of the options vest each quarter thereafter."}],"balance_after":0,"derivative":{"exercise_price":7.78,"expiration_date":"2029-04-04","underlying":"Common Shares","underlying_shares":65863},"source":{"system":"sec-edgar","filing":"0001209191-23-017715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919123017715/doc4.xml","form_type":"4"}},{"id":1958848,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-10T14:24:59.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":63717,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each then-outstanding and unexercised Issuer stock option (whether vested or unvested) was canceled and converted into the right to receive an amount (subject to any withholding tax) in cash, without interest, equal to the product of (a) the excess, if any, of (i) the Per Share Consideration over (ii) the applicable exercise price for such option, multiplied by (b) the total number of Issuer common shares subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.78,"expiration_date":"2028-04-15","underlying":"Common Shares","underlying_shares":63717},"source":{"system":"sec-edgar","filing":"0001209191-23-017715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919123017715/doc4.xml","form_type":"4"}},{"id":1958847,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-10T14:24:59.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":155300,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each then-outstanding and unexercised Issuer stock option (whether vested or unvested) was canceled and converted into the right to receive an amount (subject to any withholding tax) in cash, without interest, equal to the product of (a) the excess, if any, of (i) the Per Share Consideration over (ii) the applicable exercise price for such option, multiplied by (b) the total number of Issuer common shares subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":155300},"source":{"system":"sec-edgar","filing":"0001209191-23-017715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919123017715/doc4.xml","form_type":"4"}},{"id":1958846,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2023-03-10T14:24:59.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":160082,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects restricted stock units (\"RSUs\").  Each RSU outstanding immediately prior to the Effective Time that had not been settled in Issuer common shares was canceled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash, without interest, equal to the product of (a) the Per Share Consideration, multiplied by (b) the total number of Issuer common shares subject to such RSU immediately prior to the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-017715","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919123017715/doc4.xml","form_type":"4"}},{"id":1958845,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2023-03-10T14:24:59.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":86602,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each common share of the Issuer outstanding immediately prior to the Effective Time (other than certain excluded shares) automatically converted into the right to receive $27.00 in cash, without interest and less any applicable withholding taxes (the \"Per Share Consideration\")."}],"balance_after":160082,"source":{"system":"sec-edgar","filing":"0001209191-23-017715","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919123017715/doc4.xml","form_type":"4"}},{"id":2049739,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2023-01-20T21:31:36.000Z","date":"2023-01-18","kind":"sale","acquired":false,"shares":1109,"price":26.89,"value":29821.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":246684,"source":{"system":"sec-edgar","filing":"0001209191-23-004277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919123004277/doc4.xml","form_type":"4"}},{"id":2062826,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2023-01-05T22:21:44.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":2251,"price":26.9,"value":60551.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":247793,"source":{"system":"sec-edgar","filing":"0001209191-23-001957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919123001957/doc4.xml","form_type":"4"}},{"id":2134165,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-10-20T20:50:34.000Z","date":"2022-10-18","kind":"sale","acquired":false,"shares":1604,"price":25.2,"value":40420.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":250044,"source":{"system":"sec-edgar","filing":"0001209191-22-054194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919122054194/doc4.xml","form_type":"4"}},{"id":2141330,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-10-06T20:28:34.000Z","date":"2022-10-04","kind":"sale","acquired":false,"shares":2738,"price":24.4,"value":66807.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":251648,"source":{"system":"sec-edgar","filing":"0001209191-22-052986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919122052986/doc4.xml","form_type":"4"}},{"id":2204577,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-07-20T20:35:08.000Z","date":"2022-07-18","kind":"sale","acquired":false,"shares":1606,"price":12.87,"value":20669.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":254386,"source":{"system":"sec-edgar","filing":"0001209191-22-042686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919122042686/doc4.xml","form_type":"4"}},{"id":2209929,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-07-08T20:09:42.000Z","date":"2022-07-06","kind":"sale","acquired":false,"shares":2755,"price":13.4,"value":36917.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $13.40 to $13.46. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":255992,"source":{"system":"sec-edgar","filing":"0001209191-22-041618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919122041618/doc4.xml","form_type":"4"}},{"id":2249586,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-06-01T20:20:46.000Z","date":"2022-05-27","kind":"sale","acquired":false,"shares":1382,"price":10.07,"value":13916.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":258747,"source":{"system":"sec-edgar","filing":"0001209191-22-033156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919122033156/doc4.xml","form_type":"4"}},{"id":2292762,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-04-21T20:27:06.000Z","date":"2022-04-19","kind":"sale","acquired":false,"shares":4632,"price":10.45,"value":48404.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $10.45 to $10.47. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":260129,"source":{"system":"sec-edgar","filing":"0001209191-22-025173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919122025173/doc4.xml","form_type":"4"}},{"id":2294839,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-04-19T20:51:02.000Z","date":"2022-04-15","kind":"grant","acquired":true,"shares":103703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Shares are to be acquired upon the vesting of certain Restricted Stock Units (\"RSUs\") granted to the Reporting Person. 1/4 of the common shares underlying the RSUs vest on April 15, 2023, and 1/16 of the common shares underlying the RSUs vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":264761,"source":{"system":"sec-edgar","filing":"0001209191-22-024787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919122024787/doc4.xml","form_type":"4"}},{"id":2301314,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-04-07T20:16:51.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":1922,"price":13.78,"value":26485.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $13.78 to $13.84. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":161058,"source":{"system":"sec-edgar","filing":"0001209191-22-023660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919122023660/doc4.xml","form_type":"4"}},{"id":2354772,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-03-03T21:54:19.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":1362,"price":13.35,"value":18182.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":162980,"source":{"system":"sec-edgar","filing":"0001209191-22-015559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919122015559/doc4.xml","form_type":"4"}},{"id":2441676,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2022-01-06T21:21:06.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":2271,"price":16.27,"value":36949.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":164342,"source":{"system":"sec-edgar","filing":"0001209191-22-002186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919122002186/doc4.xml","form_type":"4"}},{"id":2490659,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-12-01T21:10:52.000Z","date":"2021-11-29","kind":"sale","acquired":false,"shares":1978,"price":19.3,"value":38175.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":166613,"source":{"system":"sec-edgar","filing":"0001209191-21-067262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121067262/doc4.xml","form_type":"4"}},{"id":2522969,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-11-05T20:27:04.000Z","date":"2021-11-04","kind":"exercise","acquired":false,"shares":3100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":155300,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Stock","underlying_shares":3100},"source":{"system":"sec-edgar","filing":"0001209191-21-063166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121063166/doc4.xml","form_type":"4"}},{"id":2522968,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:27:04.000Z","date":"2021-11-03","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":158400,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001209191-21-063166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121063166/doc4.xml","form_type":"4"}},{"id":2522967,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-11-05T20:27:04.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":3100,"price":24.02,"value":74462.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $24.00 to $24.035. The reporting person will provide to the SEC, the issuer or security holder of the\nissuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":168591,"source":{"system":"sec-edgar","filing":"0001209191-21-063166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121063166/doc4.xml","form_type":"4"}},{"id":2522966,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-11-05T20:27:04.000Z","date":"2021-11-04","kind":"exercise","acquired":true,"shares":3100,"price":7.78,"value":24118.0,"ownership":{"direct":true},"balance_after":171691,"source":{"system":"sec-edgar","filing":"0001209191-21-063166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121063166/doc4.xml","form_type":"4"}},{"id":2522965,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-11-05T20:27:04.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":700,"price":24,"value":16800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."}],"balance_after":168591,"source":{"system":"sec-edgar","filing":"0001209191-21-063166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121063166/doc4.xml","form_type":"4"}},{"id":2522964,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-11-05T20:27:04.000Z","date":"2021-11-03","kind":"exercise","acquired":true,"shares":700,"price":7.78,"value":5446.0,"ownership":{"direct":true},"balance_after":169291,"source":{"system":"sec-edgar","filing":"0001209191-21-063166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121063166/doc4.xml","form_type":"4"}},{"id":2546461,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-10-07T20:03:25.000Z","date":"2021-10-05","kind":"sale","acquired":false,"shares":2738,"price":21.62,"value":59195.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":168591,"source":{"system":"sec-edgar","filing":"0001209191-21-059912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121059912/doc4.xml","form_type":"4"}},{"id":2556627,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-29T20:12:19.000Z","date":"2021-09-27","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":159100,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-058051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121058051/doc4.xml","form_type":"4"}},{"id":2556626,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-09-29T20:12:19.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":7000,"price":24.32,"value":170240.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $24.01 to $24.96. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":171329,"source":{"system":"sec-edgar","filing":"0001209191-21-058051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121058051/doc4.xml","form_type":"4"}},{"id":2556625,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-09-29T20:12:19.000Z","date":"2021-09-27","kind":"exercise","acquired":true,"shares":7000,"price":7.78,"value":54460.0,"ownership":{"direct":true},"balance_after":178329,"source":{"system":"sec-edgar","filing":"0001209191-21-058051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121058051/doc4.xml","form_type":"4"}},{"id":2585182,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-31T21:23:46.000Z","date":"2021-08-30","kind":"exercise","acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":166100,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-21-054115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121054115/doc4.xml","form_type":"4"}},{"id":2585181,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-08-31T21:23:46.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":21000,"price":24.05,"value":505050.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares sold pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold at prices ranging from $24.00 to $24.20. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":171329,"source":{"system":"sec-edgar","filing":"0001209191-21-054115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121054115/doc4.xml","form_type":"4"}},{"id":2585180,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-08-31T21:23:46.000Z","date":"2021-08-30","kind":"exercise","acquired":true,"shares":21000,"price":7.78,"value":163380.0,"ownership":{"direct":true},"balance_after":192329,"source":{"system":"sec-edgar","filing":"0001209191-21-054115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121054115/doc4.xml","form_type":"4"}},{"id":2585179,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-08-31T21:23:46.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":1978,"price":22.69,"value":44880.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":171329,"source":{"system":"sec-edgar","filing":"0001209191-21-054115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121054115/doc4.xml","form_type":"4"}},{"id":2637057,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-07-09T20:30:35.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":2777,"price":21.75,"value":60399.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $21.75 to $21.80. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":173307,"source":{"system":"sec-edgar","filing":"0001209191-21-046175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121046175/doc4.xml","form_type":"4"}},{"id":2686692,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-02T20:18:16.000Z","date":"2021-05-28","kind":"exercise","acquired":false,"shares":1300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":187100,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":1300},"source":{"system":"sec-edgar","filing":"0001209191-21-037158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121037158/doc4.xml","form_type":"4"}},{"id":2686691,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-06-02T20:18:16.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":1783,"price":24,"value":42792.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":176084,"source":{"system":"sec-edgar","filing":"0001209191-21-037158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121037158/doc4.xml","form_type":"4"}},{"id":2686690,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-06-02T20:18:16.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":1300,"price":24,"value":31200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."}],"balance_after":177867,"source":{"system":"sec-edgar","filing":"0001209191-21-037158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121037158/doc4.xml","form_type":"4"}},{"id":2686689,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-06-02T20:18:16.000Z","date":"2021-05-28","kind":"exercise","acquired":true,"shares":1300,"price":7.78,"value":10114.0,"ownership":{"direct":true},"balance_after":179167,"source":{"system":"sec-edgar","filing":"0001209191-21-037158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121037158/doc4.xml","form_type":"4"}},{"id":2691369,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-28T20:35:51.000Z","date":"2021-05-26","kind":"exercise","acquired":false,"shares":2867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":188400,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":2867},"source":{"system":"sec-edgar","filing":"0001209191-21-036551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121036551/doc4.xml","form_type":"4"}},{"id":2691368,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-28T20:35:51.000Z","date":"2021-05-26","kind":"exercise","acquired":false,"shares":9833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the common shares underlying this option vested on April 16, 2019, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":63717,"derivative":{"exercise_price":7.78,"expiration_date":"2028-04-15","underlying":"Common Shares","underlying_shares":9833},"source":{"system":"sec-edgar","filing":"0001209191-21-036551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121036551/doc4.xml","form_type":"4"}},{"id":2691367,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-05-28T20:35:51.000Z","date":"2021-05-26","kind":"sale","acquired":false,"shares":12700,"price":24.23,"value":307721.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $24.00 to $24.87. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":177867,"source":{"system":"sec-edgar","filing":"0001209191-21-036551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121036551/doc4.xml","form_type":"4"}},{"id":2691366,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-05-28T20:35:51.000Z","date":"2021-05-26","kind":"exercise","acquired":true,"shares":12700,"price":7.78,"value":98806.0,"ownership":{"direct":true},"balance_after":190567,"source":{"system":"sec-edgar","filing":"0001209191-21-036551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121036551/doc4.xml","form_type":"4"}},{"id":2745208,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-19T20:18:02.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":79472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the common shares underlying this option vest on April 15, 2022, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":79472,"derivative":{"exercise_price":17.88,"expiration_date":"2031-04-14","underlying":"Common Shares","underlying_shares":79472},"source":{"system":"sec-edgar","filing":"0001209191-21-027282","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121027282/doc4.xml","form_type":"4"}},{"id":2745207,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-04-19T20:18:02.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":51446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Shares are to be acquired upon the vesting of certain Restricted Stock Units (\"RSUs\") granted to the Reporting Person. 1/4 of the common shares underlying the RSUs vest on April 15, 2022, and 1/16 of the common shares underlying the RSUs vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":177867,"source":{"system":"sec-edgar","filing":"0001209191-21-027282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121027282/doc4.xml","form_type":"4"}},{"id":2752987,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-04-08T20:59:36.000Z","date":"2021-04-06","kind":"sale","acquired":false,"shares":8114,"price":18.63,"value":151163.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $18.60 to $19.04. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":126421,"source":{"system":"sec-edgar","filing":"0001209191-21-026091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121026091/doc4.xml","form_type":"4"}},{"id":2774942,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-23T20:23:12.000Z","date":"2021-03-19","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the common shares underlying this option vested on April 16, 2019, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":73550,"derivative":{"exercise_price":7.78,"expiration_date":"2028-04-15","underlying":"Common Shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-21-022557","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121022557/doc4.xml","form_type":"4"}},{"id":2774941,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-03-23T20:23:12.000Z","date":"2021-03-19","kind":"sale","acquired":false,"shares":7000,"price":24.17,"value":169190.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $24.01 to $24.42. The reporting person will provde upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":134535,"source":{"system":"sec-edgar","filing":"0001209191-21-022557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121022557/doc4.xml","form_type":"4"}},{"id":2774940,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-03-23T20:23:12.000Z","date":"2021-03-19","kind":"exercise","acquired":true,"shares":7000,"price":7.78,"value":54460.0,"ownership":{"direct":true},"balance_after":141535,"source":{"system":"sec-edgar","filing":"0001209191-21-022557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121022557/doc4.xml","form_type":"4"}},{"id":2814073,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2021-03-03T21:52:34.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":1513,"price":22.55,"value":34118.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":134535,"source":{"system":"sec-edgar","filing":"0001209191-21-016928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919121016928/doc4.xml","form_type":"4"}},{"id":2934842,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-22T21:34:32.000Z","date":"2020-12-18","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":191267,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-20-064830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120064830/doc4.xml","form_type":"4"}},{"id":2934841,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-12-22T21:34:32.000Z","date":"2020-12-18","kind":"sale","acquired":false,"shares":2000,"price":26,"value":52000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."}],"balance_after":136048,"source":{"system":"sec-edgar","filing":"0001209191-20-064830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120064830/doc4.xml","form_type":"4"}},{"id":2934840,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-12-22T21:34:32.000Z","date":"2020-12-18","kind":"exercise","acquired":true,"shares":2000,"price":7.78,"value":15560.0,"ownership":{"direct":true},"balance_after":138048,"source":{"system":"sec-edgar","filing":"0001209191-20-064830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120064830/doc4.xml","form_type":"4"}},{"id":2940311,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T21:54:06.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":193267,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-064098","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120064098/doc4.xml","form_type":"4"}},{"id":2940310,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-12-17T21:54:06.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":3467,"price":24.1815,"value":83837.2605,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold at prices ranging from $24.02 to $24.75. The reporting person will provde upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":136048,"source":{"system":"sec-edgar","filing":"0001209191-20-064098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120064098/doc4.xml","form_type":"4"}},{"id":2940309,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-12-17T21:54:06.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":3533,"price":23.6595,"value":83589.0135,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $23.02 to $24.01. The reporting person will provde upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":139515,"source":{"system":"sec-edgar","filing":"0001209191-20-064098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120064098/doc4.xml","form_type":"4"}},{"id":2940308,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-12-17T21:54:06.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":7000,"price":7.78,"value":54460.0,"ownership":{"direct":true},"balance_after":143048,"source":{"system":"sec-edgar","filing":"0001209191-20-064098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120064098/doc4.xml","form_type":"4"}},{"id":2946729,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-14T21:21:02.000Z","date":"2020-12-10","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":200267,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-063213","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120063213/doc4.xml","form_type":"4"}},{"id":2946728,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-12-14T21:21:02.000Z","date":"2020-12-10","kind":"sale","acquired":false,"shares":10000,"price":26.0362,"value":260362.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $26.00 to $26.20. The reporting person will provde upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":136048,"source":{"system":"sec-edgar","filing":"0001209191-20-063213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120063213/doc4.xml","form_type":"4"}},{"id":2946727,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-12-14T21:21:02.000Z","date":"2020-12-10","kind":"exercise","acquired":true,"shares":10000,"price":7.78,"value":77800.0,"ownership":{"direct":true},"balance_after":146048,"source":{"system":"sec-edgar","filing":"0001209191-20-063213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120063213/doc4.xml","form_type":"4"}},{"id":2960964,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-12-02T22:10:07.000Z","date":"2020-11-30","kind":"sale","acquired":false,"shares":1978,"price":23.65,"value":46779.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":136048,"source":{"system":"sec-edgar","filing":"0001209191-20-061223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120061223/doc4.xml","form_type":"4"}},{"id":2973261,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T22:00:43.000Z","date":"2020-11-17","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":210267,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-059445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120059445/doc4.xml","form_type":"4"}},{"id":2973260,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-11-19T22:00:43.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":7000,"price":20,"value":140000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."}],"balance_after":138026,"source":{"system":"sec-edgar","filing":"0001209191-20-059445","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120059445/doc4.xml","form_type":"4"}},{"id":2973259,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-11-19T22:00:43.000Z","date":"2020-11-17","kind":"exercise","acquired":true,"shares":7000,"price":7.78,"value":54460.0,"ownership":{"direct":true},"balance_after":145026,"source":{"system":"sec-edgar","filing":"0001209191-20-059445","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120059445/doc4.xml","form_type":"4"}},{"id":2977766,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T23:49:23.000Z","date":"2020-11-13","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":217267,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-058893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120058893/doc4.xml","form_type":"4"}},{"id":2977765,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-11-17T23:49:23.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":7000,"price":20,"value":140000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."}],"balance_after":138026,"source":{"system":"sec-edgar","filing":"0001209191-20-058893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120058893/doc4.xml","form_type":"4"}},{"id":2977764,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-11-17T23:49:23.000Z","date":"2020-11-13","kind":"exercise","acquired":true,"shares":7000,"price":7.78,"value":54460.0,"ownership":{"direct":true},"balance_after":145026,"source":{"system":"sec-edgar","filing":"0001209191-20-058893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120058893/doc4.xml","form_type":"4"}},{"id":3028639,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-17T20:18:17.000Z","date":"2020-09-15","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":224267,"derivative":{"exercise_price":7.78,"expiration_date":"2027-08-14","underlying":"Common Shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-050883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120050883/doc4.xml","form_type":"4"}},{"id":3028638,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-09-17T20:18:17.000Z","date":"2020-09-15","kind":"sale","acquired":false,"shares":100,"price":22.45,"value":2245.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."}],"balance_after":138026,"source":{"system":"sec-edgar","filing":"0001209191-20-050883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120050883/doc4.xml","form_type":"4"}},{"id":3028637,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":24130,"kind":"person","name":"Arjona Ferreira Juan Camilo","position":1,"cik":"0001714080","reported_name":"Arjona Ferreira Juan Camilo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2020-09-17T20:18:17.000Z","date":"2020-09-15","kind":"sale","acquired":false,"shares":6900,"price":21.76,"value":150144.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $21.44 to $22.30. The reporting person will provde upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":138126,"source":{"system":"sec-edgar","filing":"0001209191-20-050883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1714080/000120919120050883/doc4.xml","form_type":"4"}}],"next_cursor":"2020-09-17T20:18:17.000000Z,3028637"}